Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lifespan Vision Ventures is a venture capital firm dedicated to investing in the longevity and aging sector. The firm focuses on identifying and supporting biotechnology companies that are developing breakthrough therapies to extend healthy human lifespan and combat age-related diseases. Their investment strategy spans early-stage startups to more mature growth companies, with a particular interest in regenerative medicine, cellular reprogramming, and aging biomarkers. By providing strategic capital and industry expertise, Lifespan Vision Ventures aims to accelerate the transition of longevity science from the laboratory to clinical practice. The firm's portfolio includes innovative companies such as Longeveron and Rejuvenate Bio, reflecting a commitment to diverse therapeutic modalities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lifespan Vision Ventures.